Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Search results also available in MS Excel format.

Showing 1 to 5 of 5 found. | Sort by date

1 Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone
article 2009    
Author: Hellgren, M. · Conard, J. · Norris, L. · Kluft, C.
Keywords: Biology · Biomedical Research · Blood coagulation · Cardiovascular risk · Endometrial protection · Fibrinolysis · Hormone therapy · Lipids · Menopause · dydrogesterone · estradiol · gestagen · low density lipoprotein cholesterol · trimegestone · adult · article · cardiovascular risk · cholesterol blood level · clinical trial · controlled clinical trial · controlled study · double blind procedure · drug effect · female · fibrinolysis · human · major clinical study · postmenopause · randomized controlled trial · Adult · Aged · Biological Markers · Blood Coagulation Factors · Cardiovascular Diseases · Double-Blind Method · Drug Therapy, Combination · Dydrogesterone · Estradiol · Estrogen Replacement Therapy · Estrogens · Female · Fibrinolysis · Humans · Lipids · Middle Aged · Postmenopause · Progestins · Promegestone · Risk Factors · Thromboembolism · Uterine Hemorrhage
[Abstract]

2 Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
article 1999    
Author: Baal, W.M. van · Kenemans, P. · Emeis, J.J. · Schalkwijk, C.G. · Mijatovic, V. · Mooren, M.J. van der · Vischer, U.M. · Stehouwer, C.D.A.
Keywords: Health · E- selectin · Endothelial function · Endothelin-1 · Estrogen · Fibrinogen · Hormone replacement therapy · Inflammatory activity · Postmenopausal · Thrombomodulin · Von Willebrand factor · C reactive protein · Dydrogesterone · E-Selectin · Endothelin-1 · Endothelium, Vascular · Estradiol · Estrogen Replacement Therapy · Female · Fibrinogen · Humans · Inflammation · Middle Aged · Postmenopause · Prospective Studies · Solubility · Thrombomodulin · von Willebrand Factor
[Abstract]

3 Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review
article 2008    
Author: Hemelaar, M. · Mooren, M.J. van der · Rad, M. · Kluft, C. · Kenemans, P.
Keywords: Biology · cardiovascular disease · intranasal · Postmenopausal hormone therapy · risk factors · transdermal · venous thromboembolism · activated protein C · antithrombin · blood clotting factor 7 · C reactive protein · cell adhesion molecule · chlormadinone acetate · conjugated estrogen · cyproterone acetate plus estradiol valerate · dydrogesterone · dydrogesterone plus estradiol · endothelin 1 · estradiol · estradiol valerate · estrone sulfate · gestodene · homocysteine · hormone · lipoprotein · medrogestone · medroxyprogesterone acetate · n(g),n(g) dimethylarginine · nomegestrol acetate · norethisterone acetate · placebo · progesterone · protein C · protein S · prothrombin · article · atherosclerosis · blood clotting · cardiovascular risk · clinical trial · drug effect · drug mechanism · endothelial dysfunction · fibrinolysis · follow up · hormonal therapy · human · inflammation · ischemic heart disease · outcome assessment · postmenopause · priority journal · systematic review · venous thromboembolism · Administration, Oral · Atherosclerosis · Biological Markers · Estrogen Replacement Therapy · Estrogens · Female · Humans · Incidence · Risk Assessment · Risk Factors · Venous Thrombosis
[Abstract]

4 Sex steroids and lipoprotein metabolism
article 1994    
Author: Gevers Leuven, J.A.
Keywords: Health · Cardiovascular risk · Cholesterol · Estrogens · Lipoproteins · Progestogens · Sex steroids · chlormadinone acetate · cholesterol · conjugated estrogen · cyproterone acetate · desogestrel · dydrogesterone · gestodene · high density lipoprotein · hydroxytamoxifen · low density lipoprotein · lynestrenol · medrogestone · medroxyprogesterone acetate · mifepristone · norethisterone · noretynodrel · norgestimate · norgestrel · oral contraceptive agent · sex hormone · steroid receptor · very low density lipoprotein · atherogenesis · cardiovascular disease · drug structure · lipid metabolism · lipoprotein metabolism · Animal · Arteriosclerosis · Cardiovascular Diseases · Contraceptives, Oral, Hormonal · Female · Human · Lipoproteins · Male · Risk Factors · Sex Hormones
[Abstract]

5 Inhibitors and activation markers of the haemostatic system during hormone therapy: A comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone
article 2008    
Author: Norris, L.A. · Brosnan, J. · Bonnar, J. · Conard, J. · Kluft, C. · Hellgren, M.
Keywords: Health · Haemostasis · Hormones · Venous thrombosis · Activated protein C · Antiplasmin · Antithrombin · Blood clotting factor 5 Leiden · Dydrogesterone plus estradiol · Estradiol plus trimegestone · Estrogen derivative · Plasmin · Protein S · Prothrombin · Adult · Aged · Clinical trial · Controlled clinical trial · Controlled study · Double blind procedure · Drug effect · Drug inhibition · Female · Fibrinolysis · Gene mutation · Hormonal therapy · Human · Medical assessment · Multicenter study · Multiple cycle treatment · Postmenopause · Protein blood level · Protein function · Randomized controlled trial · Administration, Oral · Estrogen Replacement Therapy · Factor V · Hemostasis · Humans · Middle Aged · Progestins · Promegestone · Protein C · Protein S · Risk Factors · Venous Thrombosis
[Abstract]

Search results also available in MS Excel format.

Showing 1 to 5 of 5 found. | Sort by date